Clinical Significance of Serum Biomarkers: Vascular Endothelial Growth Factor-A and Chemokine (C-X-C motif) Ligand 13 in Egyptian Multiple Myeloma Patients

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Kassem Neemat M.; Saadeldin Ibtessam; Zawam Hussam; Kassem Hebatallah A.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: ACTA MEDICA IRANICA Year:2023 | Volume:61 | Issue:3 Page(s): 150-160

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

Clinical Significance of Serum Biomarkers: Vascular Endothelial Growth Factor-A and Chemokine (C-X-C motif) Ligand 13 in Egyptian Multiple Myeloma Patients

Author(s)

Kassem Neemat M. | Saadeldin Ibtessam | Zawam Hussam | Kassem Hebatallah A. | Issue Writer Certificate

Keywords

Vascular endothelial growth factor

A (VEGF

Chemokine (C

C motif) ligand 13 (CXCL13)

Multiple myeloma

Clinical outcome

Abstract

Multiple myeloma (MM) is a human B-cell neoplasia arising from malignant plasma cells. Vascular endothelial growth factor (VEGF) is among growth factors essential for angiogenesis in MM. However, chemokine (C-X-C motif) ligand 13 (CXCL13) allows the chemotaxis of mature B cells expressing its receptor CXCR5. CXCL13-CXCR5 interactions are involved in MM progression. This study aimed at investigating 2 serum biomarkers,VEGF-A and CXCL13 levels using enzyme linked immunosorbent assays (ELISA) in 48 Egyptian myeloma patients as well as correlation with different clinic-pathological features, survival and therapy response. VEGF-A and CXCL13 levels were significantly higher in MM cases in comparison to control group (P=0. 04* and 0. 01*, respectively). An indirect proportional relation between VEGF-A and CXCL13 levels in myeloma patients was found (r=-0. 27, P=0. 22). Alb/creat ratio change showed indirect proportional relation with VEGF-A (r=-0. 446, P=0. 043*). Patients obtained complete remission (CR)had insignificantly lower VEGF-A and higher CXCL13 levels compared to other patients, P=0. 2 and 0. 7, respectively. In conclusion, production of variety of growth factors and cytokines such as VEGF-A and CXCL13 was higher in MM patients. However, our experiment has to be done on larger sample size and extended period of follow up to validate the participation of the VEGF-A and CXCL13 in disease progression and clinical outcome.

Cites

No record.

References

CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression

Cite

APA: Copy

Kassem, Neemat M., Saadeldin, Ibtessam, Zawam, Hussam, & Kassem, Hebatallah A.. (2023). Clinical Significance of Serum Biomarkers: Vascular Endothelial Growth Factor-A and Chemokine (C-X-C motif) Ligand 13 in Egyptian Multiple Myeloma Patients. ACTA MEDICA IRANICA, 61(3), 150-160. SID. https://sid.ir/paper/1101716/en

Vancouver: Copy

Kassem Neemat M., Saadeldin Ibtessam, Zawam Hussam, Kassem Hebatallah A.. Clinical Significance of Serum Biomarkers: Vascular Endothelial Growth Factor-A and Chemokine (C-X-C motif) Ligand 13 in Egyptian Multiple Myeloma Patients. ACTA MEDICA IRANICA[Internet]. 2023;61(3):150-160. Available from: https://sid.ir/paper/1101716/en

IEEE: Copy

Neemat M. Kassem, Ibtessam Saadeldin, Hussam Zawam, and Hebatallah A. Kassem, “Clinical Significance of Serum Biomarkers: Vascular Endothelial Growth Factor-A and Chemokine (C-X-C motif) Ligand 13 in Egyptian Multiple Myeloma Patients,” ACTA MEDICA IRANICA, vol. 61, no. 3, pp. 150–160, 2023, [Online]. Available: https://sid.ir/paper/1101716/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops